Skip to content
Biodatica
Start free

Investigator

William H. Gmeiner

DEEP CREEK PHARMA, LLC · funded by NCI

Companies
1

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$979k

Summed across those awards.

First award
Jul 1, 2023

Latest Sep 2, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R41

    Modified Thrombin Binding Aptamer Treatment of CRC Metastasis

    $400k

    Sep 2, 2025NCIDEEP CREEK PHARMA, LLCNIH RePORTER · 11255090 (opens the source filing in a new tab)

  2. R01

    Nanodelivery of FP polymers to improve treatment of metastatic colorectal cancer

    $579k

    Jul 1, 2023NCIWAKE FOREST UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11124810 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources